Interview with the Innovators

Setting Realistic Treatment Goals and Expectations for Patients with Transthyretin Amyloidosis

Ola Akinboboye, MD, MPH, MBA
Clinical Professor, Cardiology
Donald and Barbara Zucker School of Medicine at Hofstra/Northwell & Medical Director
Laurelton Heart Specialists PC
Rosedale, NY
Clement C. Eiswirth, Jr., MD, FACC
Medical Director
Cardiomyopathy and Heart Failure Program, Ochsner Health
New Orleans, LA
Ola Akinboboye, MD, MPH, MBA, Clinical Professor, Cardiology, Donald and Barbara Zucker School of Medicine at Hofstra University/Northwell Health and Medical Director, Laurelton Heart Specialists PC (Rosedale, NY) and Clement C. Eiswirth, Jr., MD, FACC, Medical Director, Cardiomyopathy and Heart Failure Program, Ochsner Health, New Orleans, LA, highlight the importance of early diagnosis and realistic expectations for patients being treated for transthyretin amyloidosis.

Related Items

Subscribe to Amyloidosis News

Stay up to date with Amyloidosis News & updates by subscribing to receive the free AMN e‑Newsletter.

I'd like to recieve: